FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 叮噹健康科技集團有限公司 呈交日期： 2025年12月22日 FF305 | 1). | 已購回以作註銷但尚未註銷之股份 | | 410,000 | 0.031073 % | HKD | 1.051 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年11月25日 | | | | | | 2). | 已購回以作註銷但尚未註銷之股份 | | 170,000 | 0.012884 % | HKD | 1.0533 | | | 變動日期 | 2025年11月26日 | | | | | | 3). | 已購回以作註銷但尚未註銷之股份 | | 69,000 | 0.005229 % | HKD | 1.0787 | | | 變動日期 | 2025年11月27日 | | | | | | 4). | 已購回以作註銷但尚未註銷之股份 | | 251,000 | 0.019023 % | HKD | 1. ...

Group 1 - Dingtang Health repurchased 540,000 shares at an average price of 1.08 HKD per share, totaling approximately 585,800 HKD, with a cumulative repurchase of 7.32 million shares this year, representing 0.55% of the total share capital [1] - The company's stock price increased by 3.81% to 1.09 HKD per share following the repurchase announcement [1] - The repurchase activity is interpreted as a response from the management to the perceived undervaluation of the stock and reflects confidence in future growth [1] Group 2 - Dingtang Health focuses on digital healthcare services, including online consultations, drug delivery, and health management services, utilizing platforms like "Dingtang Fast Medicine" [2] - The company has been expanding its business boundaries through partnerships with various medical institutions and pharmaceutical companies, creating an integrated health ecosystem [2] - Despite intense competition in the industry, Dingtang Health holds certain advantages in instant drug delivery and digital services, with its Hong Kong listing providing capital support for future development [2]

叮当健康(09886.HK)12月18日耗资15.3万港元回购14.5万股 叮当健康(09886.HK)12月17日耗资10万港元 回购9.5万股 相关事件 格隆汇12月19日丨叮当健康(09886.HK)公告，12月19日耗资58.6万港元回购54万股。 ...

Group 1 - The company Dingdang Health (09886) announced a share buyback plan on December 19, 2025, involving an expenditure of HKD 585,800 to repurchase 540,000 shares [1] - The repurchase price per share ranges from HKD 1.05 to HKD 1.11 [1]

Group 1 - The core announcement is that Dingdang Health (09886) plans to repurchase 540,000 shares at a total cost of HKD 585,800 [1] - The repurchase price per share ranges from HKD 1.05 to HKD 1.11 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 叮噹健康科技集團有限公司 呈交日期： 2025年12月19日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09886 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包 ...

Group 1 - The article reports on share buybacks conducted by various companies on December 18, 2025, with Tencent Holdings leading in both the number of shares repurchased and the total amount spent [1] - Tencent Holdings repurchased 1.055 million shares for a total of 636 million yuan, representing 1.030% of its total share capital for the year [2] - Other notable companies involved in the buyback include Xiaomi Group, which repurchased 3.75 million shares for 151 million yuan, and China National Petroleum Corporation, which repurchased 254,000 shares for 116.38 million yuan [3] Group 2 - The total number of shares repurchased by companies varied significantly, with China National Petroleum Corporation having a cumulative buyback of 230 million shares, which is 0.190% of its total share capital [3] - Companies like IGG and VITASOY also participated, with IGG repurchasing 182,000 shares for 68.49 million yuan and VITASOY repurchasing 122,000 shares for 77.94 million yuan [3] - The buyback activity reflects a strategic move by these companies to enhance shareholder value and manage their capital structure effectively [1][2]

叮当健康(09886)公布，2025年12月18日耗资约15.28万港元回购14.5万股股份。 ...

智通财经APP讯，叮当健康(09886)公布，2025年12月18日耗资约15.28万港元回购14.5万股股份。 ...

格隆汇12月18日丨叮当健康(09886.HK)公告，12月18日耗资15.3万港元回购14.5万股。 ...